Alterity Therapeutics annual shares outstanding
2021
2022
2023
Alterity Therapeutics Shares Outstanding History (ATHE)
Alterity Therapeutics reported 2.44B shares outstanding at the end of fiscal 2023.
View full Alterity Therapeutics company overviewAlterity Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-06-30 | 2.44B | 33.0M | +1.37% |
| 2022 | 2022-06-30 | 2.41B | 322.9M | +15.49% |
| 2021 | 2021-06-30 | 2.08B | — | — |
Alterity Therapeutics quarterly shares outstanding
Q4.21
Q4.22
Q4.23
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-06-30 | 2.44B | — | — |
| Q4 2022 | 2022-06-30 | 2.41B | — | — |
| Q4 2021 | 2021-06-30 | 2.08B | — | — |
Alterity Therapeutics shares outstanding trends
Across the available reported history, Alterity Therapeutics's shares outstanding moved from 2.41B to 2.44B, a change of 33.0M. The latest reported quarter, Q4 2023, shows 2.44B.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alterity Therapeutics filings at SEC.gov ↗